Non small cell lung cancer patients with EGFR mutation : therapeutic sequences in a real life setting

被引：0
|
作者：
Berardi, G. [1 ]
Girard, N. [2 ]
De Fraipont, F. [3 ]
Decroisette, C. [4 ]
Gazzerie, S. [5 ]
Sibilot, D. Moro [1 ]
Toffart, A. C. [1 ]
机构：
[1] CHU Grenoble Alpes, Serv Pneumol & Physiol Resp, Grenoble, France
[2] Inst Thorax Curie Montsouris, Serv Pneumol, Paris, France
[3] CHU Grenoble Alpes, Serv Biol & Pathol, Grenoble, France
[4] CH Annecy Genevois, Serv Pneumol, Annecy, France
[5] Univ Grenoble Alpes, Inst Avancee Biosci, Grenoble, France
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.2053
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2053
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation
    Morinaga, Ryotaro
    Okamoto, Isamu
    Furuta, Kazuyuki
    Kawano, Yukiko
    Sekijima, Masaru
    Dote, Kensaku
    Satou, Takao
    Nishio, Kazuto
    Fukuoka, Masahiro
    Nakagawa, Kazuhiko
    LUNG CANCER, 2007, 58 (03) : 411 - 413
  • [32] EGFR mutation and response to chemotherapy in non-small-cell lung cancer (NSCLC) patients.
    Lee, KH
    Han, SW
    Jeong, S
    Kim, DW
    Chung, DH
    Im, SA
    Kim, TY
    Heo, DS
    Bang, YJ
    Kim, NK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 641S - 641S
  • [33] KRAS mutation is highly correlated with EGFR alterations in patients with non-small cell lung cancer
    Wang, J. -Y.
    Lin, S. -R.
    EJC SUPPLEMENTS, 2009, 7 (04): : 37 - 37
  • [34] Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non-Small-Cell Lung Cancer
    Bai, Hua
    Wang, Zhijie
    Chen, Keneng
    Zhao, Jun
    Lee, J. Jack
    Wang, Shuhang
    Zhou, Qinghua
    Zhuo, Minglei
    Mao, Li
    An, Tongtong
    Duan, Jianchun
    Yang, Lu
    Wu, Meina
    Liang, Zhen
    Wang, Yuyan
    Kang, Xiaozheng
    Wang, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) : 3077 - 3083
  • [35] The predictive value of uncommon EGFR mutation in patients with non-small-cell lung cancer.
    Tu, Haiyan
    Ke, Ee
    Sun, Yue-Li
    Zheng, Ming-Ying
    Yang, Jin-Ji
    Wang, Zhen
    Wu, Si-Pei
    Su, Jian
    Zhang, Xuchao
    Bai, Xiao-Yan
    Yang, Xue-Ning
    Zhong, Wenzhao
    Yan, Hong-Hong
    Zhou, Qing
    Wu, Yi-Long
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] Analysis of the EGFR gene mutation in patients with non-small cell lung cancer in a Chinese population
    Li, Ju-yi
    Liu, Ying
    Deng, Ai-ping
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 15 (08) : 1637 - 1641
  • [37] A single centre experience of gefitinib in patients with EGFR mutation positive non small cell lung cancer
    Walter, H. S.
    Fennell, D. A.
    Ahmed, S. I.
    LUNG CANCER, 2013, 79 : S7 - S7
  • [38] EGFR Gene Mutation and Methodological Evaluation in 399 Patients with Non-small Cell Lung Cancer
    Hong-yun Zheng
    Hai-bo Wang
    Fu-jin Shen
    Yong-qing Tong
    Qian Yao
    Bin Qiao
    Si Sun
    Yan Li
    Current Medical Science, 2020, 40 : 78 - 84
  • [39] EGFR Gene Mutation and Methodological Evaluation in 399 Patients with Non-small Cell Lung Cancer
    Zheng, Hong-yun
    Wang, Hai-bo
    Shen, Fu-jin
    Tong, Yong-qing
    Yao, Qian
    Qiao, Bin
    Sun, Si
    Li, Yan
    CURRENT MEDICAL SCIENCE, 2020, 40 (01) : 78 - 84
  • [40] Cardiovascular events in eGFR-mutation non-small-cell lung cancer patients on osimertinib
    Mensah, Samuel Akaakole
    Ahmad, Syed
    Alruwaili, Waleed
    Raval, Rutu
    Gonuguntla, Karthik
    Patel, Brijesh
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024,
12345